Skip to main content
Livermore
Livermore
ZHEN

Carmignac Gestion

SEC CIK
0001569758
Latest filing
Aug 13, 2026

The latest 13F from Carmignac Gestion covers Q2 2026 (filed Aug 13, 2026): 94 long positions worth $7.71B. The top 10 holdings make up 60.5% of the portfolio, and the largest is NVIDIA Corp (NVDA) at 12.5%. Livermore has 23 filings on Form 13F from this institution, going back to Q1 2021.

What changed in Q2 2026

Share counts compared with Q1 2026: how many positions were new, added to, reduced or sold out, and the biggest buys and sells. Dollar amounts are estimated at the quarter-end prices implied by the filing.

Full comparison
New
26
Est. +$315.5M
Added
36
Est. +$1.92B
Reduced
22
Est. −$875.6M
Sold out
40
Est. −$491.0M

Top 5 holdings

Share of this quarter's portfolio value

  1. NVDANVIDIA Corp
    12.5%$959.4MHistory
  2. AVGOBroadcom Inc.
    6.6%$511.5MHistory
  3. CORCencora, Inc.
    6.4%$494.5MHistory
  4. MCKMcKesson Corp
    6.1%$473.7MHistory
  5. GOOGLAlphabet Inc.
    5.4%$412.5MHistory

Share of portfolio

Top 5 holdings and the other 89 positions, by share of portfolio value

  1. NVDA12.5%
  2. AVGO6.6%
  3. COR6.4%
  4. MCK6.1%
  5. GOOGL5.4%
  6. Other 89 positions63.0%

Biggest buys

New and added positions, by estimated amount bought

  1. AVGOBroadcom Inc.
    +$306.9MAddedHistory
  2. MCKMcKesson Corp
    +$233.6MAddedHistory
  3. CORCencora, Inc.
    +$182.8MAddedHistory
  4. MAMastercard Inc
    +$180.8MAddedHistory
  5. TWTradeweb Markets Inc.
    +$158.5MAddedHistory

Largest weight increases

New and added positions, by percentage points of the portfolio gained

  1. AVGOBroadcom Inc.
    +4.06 pp2.6% → 6.6%History
  2. MAMastercard Inc
    +1.96 pp2.9% → 4.9%History
  3. MCKMcKesson Corp
    +1.92 pp4.2% → 6.1%History
  4. MSFTMicrosoft Corp
    +1.79 pp1.2% → 3.0%History
  5. BRK.BBerkshire Hathaway Inc
    +1.57 pp3.0% → 4.6%History

Biggest sells

Reduced and sold-out positions, by estimated amount sold

  1. CRMSalesforce, Inc.
    −$181.8MSold outHistory
  2. XYZBlock, Inc.
    −$148.0MReducedHistory
  3. AMZNAmazon Com Inc
    −$135.5MReducedHistory
  4. ANETArista Networks, Inc.
    −$114.3MReducedHistory
  5. NOWServiceNow, Inc.
    −$113.4MReducedHistory

Largest weight decreases

Reduced and sold-out positions, by percentage points of the portfolio lost

  1. CRMSalesforce, Inc.
    −2.79 pp2.8% → 0.0%History
  2. MELIMercadolibre Inc
    −2.44 pp6.6% → 4.2%History
  3. NOWServiceNow, Inc.
    −1.95 pp2.4% → 0.5%History
  4. AMZNAmazon Com Inc
    −1.91 pp4.5% → 2.6%History
  5. XYZBlock, Inc.
    −1.72 pp3.0% → 1.3%History

Metrics

13F metrics for Q2 2026, computed only from the numbers in the filings. Definitions below.

Portfolio value
$7.71B
+$1.20B (+18.4%) vs. prior quarter
Positions
94
−14 vs. prior quarter
Top 10 concentration
60.5%
Top 10 as share of value
Turnover
19.2%
Q2 2026, one quarter
Average holding period
12.7 quarters
Weighted by value

How these are calculated

  • Portfolio value: the market value of all long positions in the 13F, as reported at quarter end, excluding options.
  • Top 10 concentration: the combined value of the 10 largest positions as a share of portfolio value.
  • Turnover: the smaller of this quarter's estimated purchases and estimated sales, divided by the average of this and last quarter's portfolio value. Estimates multiply the change in shares by the quarter-end price implied by the filing (market value divided by shares); new positions use this quarter's value and sold-out positions last quarter's. Only positions reported in shares count, and it is not calculated when the previous quarter was not filed.
  • Average holding period: how many consecutive quarters each current position has been held (including this one; a quarter without the position or without a filing starts the count over), weighted by this quarter's value. Counting starts with the first 13F in Livermore (Q1 2021), so positions held before then are understated.

13F filings by quarter

22 quarters, going back to Q1 2021. Bars show each quarter's 13F portfolio value; quarters without a filing are left blank.

Peak $8.67B (Q1 2021)

Q1 2021: $8.67BQ2 2021: $8.55BQ3 2021: $7.98BQ4 2021: $7.13BQ1 2022: $6.18BQ2 2022: $4.72BQ3 2022: $4.65BQ4 2022: $5.54BQ1 2023: $6.00BQ2 2023: $5.80BQ3 2023: $5.44BQ4 2023: $5.95BQ1 2024: $6.32BQ2 2024: $5.83BQ3 2024: $5.99BQ4 2024: $6.27BQ1 2025: $6.09BQ2 2025: $6.50BQ3 2025: $6.71BQ4 2025: $7.39BQ1 2026: $6.51BQ2 2026: $7.71B
Q1 2021Q2 2026
13F filings of Carmignac Gestion by quarter
QuarterFiledPositionsValueTop 3 holdingsChangesFiling
Q2 2026Aug 13, 202694$7.71BNVDAAVGOCORvs. Q1 2026SEC
Q1 2026Jun 15, 2026108$6.51BNVDAMELISPGIvs. Q4 2025SEC
Q4 2025Feb 13, 2026119$7.39BNVDAMSFTSPGIvs. Q3 2025SEC
Q3 2025Nov 13, 2025126$6.71BNVDAGOOGLAMZNvs. Q2 2025SEC
Q2 2025Aug 13, 2025122$6.50BNVDAAMZNGOOGLvs. Q1 2025SEC
Q1 2025May 14, 2025152$6.09BAMZNNVDAMCKvs. Q4 2024SEC
Q4 2024Feb 13, 2025148$6.27BAMZNMSFTNVDAvs. Q3 2024SEC
Q3 2024Nov 13, 2024167$5.99BAMZNSLBMSFTvs. Q2 2024SEC
Q2 2024Aug 13, 2024155$5.83BMSFTAMZNGOOGLvs. Q1 2024SEC
Q1 2024May 14, 2024140$6.32BMETAMSFTAMDvs. Q4 2023SEC
Q4 2023Feb 13, 2024144$5.95BLLYMSFTMETAvs. Q3 2023SEC
Q3 2023Nov 29, 2023Amended144$5.44BLLYMSFTAMZNvs. Q2 2023SEC
Q2 2023Aug 11, 2023157$5.80BLLYMSFTAMZNvs. Q1 2023SEC
Q1 2023May 12, 2023134$6.00BMSFTBABALLYvs. Q4 2022SEC
Q4 2022Feb 13, 2023135$5.54BBABAMSFTORCLvs. Q3 2022SEC
Q3 2022Nov 10, 2022127$4.65BAMZNSLBMSFTvs. Q2 2022SEC
Q2 2022Aug 12, 2022117$4.72BSLBJDLLYvs. Q1 2022SEC
Q1 2022May 13, 2022112$6.18BMSFTAMZNUBERvs. Q4 2021SEC
Q4 2021Feb 11, 2022121$7.13BUBERJDAMZNvs. Q3 2021SEC
Q3 2021Nov 12, 2021118$7.98BJDCRMAMZNvs. Q2 2021SEC
Q2 2021Aug 13, 2021125$8.55BMETAJDMSFTvs. Q1 2021SEC
Q1 2021May 14, 2021129$8.67BJDMETAMSFT–SEC

13D and 13G filings

Companies where Carmignac Gestion reports owning 5% or more on Schedule 13D or 13G, and its latest filings.

Current stakes of 5% or more

Carmignac Gestion does not currently report owning 5% or more of any company.

Latest filings

3 filings on file made by Carmignac Gestion or listing it as a reporting person, newest first.

Schedule 13D and 13G filings by Carmignac Gestion
CompanyFiled (ET)FormStakeChangeEvent dateFiling
CLSDClearside Biomedical, Inc.Feb 13, 202313G/AOld format–––SEC
CLSDClearside Biomedical, Inc.Feb 9, 202213G/AOld format–––SEC
CLSDClearside Biomedical, Inc.Feb 12, 202113GOld format–New–SEC